Home
QURE
QURE News

Latest uniQure N.V. (QURE) News on July 27, 2024

Wall Street Analysts See a 125.9% Upside in uniQure (QURE): Can the Stock Really Move This High?

Zacks

11 hours ago

Wall Street Analysts See a 125.9% Upside in uniQure (QURE): Can the Stock Really Move This High?

MT Newswires

3 days ago

UniQure Completes Sale of Facility to Genezen

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen

GlobeNewswire

4 days ago

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen

uniQure’s shares soar on positive data for Huntington’s gene therapy

Clinical Trials Arena

15 days ago

uniQure’s shares soar on positive data for Huntington’s gene therapy

Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure

Zacks

15 days ago

Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure

Wall Street Analysts Think uniQure (QURE) Could Surge 195.8%: Read This Before Placing a Bet

Zacks

16 days ago

Wall Street Analysts Think uniQure (QURE) Could Surge 195.8%: Read This Before Placing a Bet

uniQure (QURE) Soars on New Huntington's Disease Study Data

Zacks

16 days ago

uniQure (QURE) Soars on New Huntington's Disease Study Data

uniQure (QURE) Surges 76.5%: Is This an Indication of Further Gains?

Zacks

17 days ago

uniQure (QURE) Surges 76.5%: Is This an Indication of Further Gains?

Down -29.74% in 4 Weeks, Here's Why You Should You Buy the Dip in uniQure (QURE)

Zacks

17 days ago

Down -29.74% in 4 Weeks, Here's Why You Should You Buy the Dip in uniQure (QURE)

UniQure stock surges on data for Huntington’s gene therapy

BioPharma Dive

18 days ago

UniQure stock surges on data for Huntington’s gene therapy

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease

GlobeNewswire

18 days ago

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease

uniQure N.V. (NASDAQ:QURE) is a favorite amongst institutional investors who own 52%

Simply Wall St.

a month ago

uniQure N.V. (NASDAQ:QURE) is a favorite amongst institutional investors who own 52%

MT Newswires

a month ago

uniQure's Commercial Gene Therapy Operations to be Acquired by Genezen

uniQure Announces Sale of Commercial Manufacturing Facility to Genezen

GlobeNewswire

a month ago

uniQure Announces Sale of Commercial Manufacturing Facility to Genezen

Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA

PR Newswire

a month ago

Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA

UniQure, with sale of plant, outsources Hemgenix manufacturing

BioPharma Dive

a month ago

UniQure, with sale of plant, outsources Hemgenix manufacturing

MT Newswires

2 months ago

UniQure Shares Rise After US FDA Grants Regenerative Medicine Advanced Designation for Huntington's Treatment

uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease

GlobeNewswire

2 months ago

uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease

uniQure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

3 months ago

uniQure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Associated Press Finance

3 months ago

UniQure: Q1 Earnings Snapshot

uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

GlobeNewswire

3 months ago

uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

13 Best Biotech Stocks To Buy Under $20

Insider Monkey

4 months ago

13 Best Biotech Stocks To Buy Under $20

uniQure N.V. (NASDAQ:QURE) Just Reported And Analysts Have Been Cutting Their Estimates

Simply Wall St.

5 months ago

uniQure N.V. (NASDAQ:QURE) Just Reported And Analysts Have Been Cutting Their Estimates

uniQure NV CEO Matthew Kapusta Sells 27,904 Shares

GuruFocus.com

5 months ago

uniQure NV CEO Matthew Kapusta Sells 27,904 Shares

uniQure NV (QURE) Reports 2023 Financial Results Amid Strategic Reorganization

GuruFocus.com

5 months ago

uniQure NV (QURE) Reports 2023 Financial Results Amid Strategic Reorganization

UniQure (QURE) Reports Q4 Loss, Tops Revenue Estimates

Zacks

5 months ago

UniQure (QURE) Reports Q4 Loss, Tops Revenue Estimates

uniQure Announces 2023 Financial Results and Highlights Recent Company Progress

GlobeNewswire

5 months ago

uniQure Announces 2023 Financial Results and Highlights Recent Company Progress

12 Best Medical Stocks to Buy Under $10

Insider Monkey

5 months ago

12 Best Medical Stocks to Buy Under $10

Compared to Estimates, OneWater Marine (ONEW) Q1 Earnings: A Look at Key Metrics

Zacks

6 months ago

Compared to Estimates, OneWater Marine (ONEW) Q1 Earnings: A Look at Key Metrics

Argan (NYSE:AGX) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

6 months ago

Argan (NYSE:AGX) Hasn't Managed To Accelerate Its Returns

Bargain Hunting in 2024: 2 Cheap Stocks to Buy With the Market at an All-Time High

Motley Fool

6 months ago

Bargain Hunting in 2024: 2 Cheap Stocks to Buy With the Market at an All-Time High

Blackstone and Other Asset Manager Stocks Have Soared. Earnings Shouldn’t Disappoint.

Barrons.com

6 months ago

Blackstone and Other Asset Manager Stocks Have Soared. Earnings Shouldn’t Disappoint.

MyCase and Clearbrief Launch Dynamic A.I. Integration, Transforming Workflows For Legal Professionals

Business Wire

6 months ago

MyCase and Clearbrief Launch Dynamic A.I. Integration, Transforming Workflows For Legal Professionals

Apparel Retailer Stocks Q3 Recap: Benchmarking Victoria's Secret (NYSE:VSCO)

StockStory

6 months ago

Apparel Retailer Stocks Q3 Recap: Benchmarking Victoria's Secret (NYSE:VSCO)

Kicking Around Preliminary Earnings Trends in the Consumer Space

GuruFocus.com

6 months ago

Kicking Around Preliminary Earnings Trends in the Consumer Space

Independent Bank Corporation Reports 2023 Fourth Quarter Results

GlobeNewswire

6 months ago

Independent Bank Corporation Reports 2023 Fourth Quarter Results

Could Buying 18%-Yielding Dividend Stock Medical Properties Trust Be a Smart Move Right Now?

Motley Fool

6 months ago

Could Buying 18%-Yielding Dividend Stock Medical Properties Trust Be a Smart Move Right Now?

Vehicle Retailer Stocks Q3 Teardown: CarMax (NYSE:KMX) Vs The Rest

StockStory

6 months ago

Vehicle Retailer Stocks Q3 Teardown: CarMax (NYSE:KMX) Vs The Rest

DSW Parent Designer Brands Taps Andrea O’Donnell as Brands President

WWD

6 months ago

DSW Parent Designer Brands Taps Andrea O’Donnell as Brands President

Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today

Motley Fool

6 months ago

Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today

Dividend Challengers List Ranked By Yield: Top 30

Insider Monkey

6 months ago

Dividend Challengers List Ranked By Yield: Top 30

Here's Why We Think Metropolitan Bank Holding (NYSE:MCB) Is Well Worth Watching

Simply Wall St.

6 months ago

Here's Why We Think Metropolitan Bank Holding (NYSE:MCB) Is Well Worth Watching

Natural Grocers® Invites Gunnison, CO Community to Grand Opening Celebration on January 31, 2024

PR Newswire

6 months ago

Natural Grocers® Invites Gunnison, CO Community to Grand Opening Celebration on January 31, 2024

Surmodics to Host Virtual Annual Meeting of Shareholders

Business Wire

6 months ago

Surmodics to Host Virtual Annual Meeting of Shareholders

GNL vs. CDP: Which Stock Is the Better Value Option?

Zacks

6 months ago

GNL vs. CDP: Which Stock Is the Better Value Option?

Daktronics to Present at January 2024 Investor Conferences

GlobeNewswire

6 months ago

Daktronics to Present at January 2024 Investor Conferences

Charles Brandes Adjusts Position in Netgear Inc

GuruFocus.com

7 months ago

Charles Brandes Adjusts Position in Netgear Inc

These Stocks Moved the Most Today: Juniper, Intuitive Surgical, Meta, Aehr Test Systems, WD-40, Home Depot, Lennar, and More

Barrons.com

7 months ago

These Stocks Moved the Most Today: Juniper, Intuitive Surgical, Meta, Aehr Test Systems, WD-40, Home Depot, Lennar, and More

Why Aehr Test Systems Stock Plunged Today

Motley Fool

7 months ago

Why Aehr Test Systems Stock Plunged Today

Ready Capital Exceeds $1 Billion in Affordable Multifamily Loan Closings During 2023

GlobeNewswire

7 months ago

Ready Capital Exceeds $1 Billion in Affordable Multifamily Loan Closings During 2023

7 Small-Cap Stocks With Huge Potential Flying Under the Radar

InvestorPlace

7 months ago

7 Small-Cap Stocks With Huge Potential Flying Under the Radar

Aehr Test Systems (NASDAQ:AEHR) Q2 2024 Earnings Call Transcript

Insider Monkey

7 months ago

Aehr Test Systems (NASDAQ:AEHR) Q2 2024 Earnings Call Transcript

Is North American Construction Group (NOA) Stock Undervalued Right Now?

Zacks

7 months ago

Is North American Construction Group (NOA) Stock Undervalued Right Now?

Why Community Health (CYH) Shares Are Attracting Investors Now

Zacks

7 months ago

Why Community Health (CYH) Shares Are Attracting Investors Now

Nature’s Sunshine Announces Participation at the 26th Annual Needham Growth Conference on January 19, 2024

GlobeNewswire

7 months ago

Nature’s Sunshine Announces Participation at the 26th Annual Needham Growth Conference on January 19, 2024

Bitcoin mining stocks tumble after double-digital gains

Yahoo Finance Video

7 months ago

Bitcoin mining stocks tumble after double-digital gains

SandRidge Energy, Inc.'s (NYSE:SD) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Simply Wall St.

7 months ago

SandRidge Energy, Inc.'s (NYSE:SD) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Disney (DIS) Unveils Zootopia-Inspired Theme Park in China

Zacks

7 months ago

Disney (DIS) Unveils Zootopia-Inspired Theme Park in China

Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme

Business Wire

7 months ago

Exscientia Announces Expansion of its Current Collaboration with Sanofi to Include Existing Exscientia Programme

TrueBlue Recognized for Women in Leadership

PR Newswire

7 months ago

TrueBlue Recognized for Women in Leadership

Investors still aren’t sold on UniQure’s gene therapy for Huntington’s

BioPharma Dive

7 months ago

Investors still aren’t sold on UniQure’s gene therapy for Huntington’s

uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease

GlobeNewswire

7 months ago

uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease

Skeena Closes C$81 Million Financing with Franco-Nevada

ACCESSWIRE

7 months ago

Skeena Closes C$81 Million Financing with Franco-Nevada

Market Cool On Daktronics, Inc.'s (NASDAQ:DAKT) Revenues Pushing Shares 26% Lower

Simply Wall St.

7 months ago

Market Cool On Daktronics, Inc.'s (NASDAQ:DAKT) Revenues Pushing Shares 26% Lower

Insider Sell Alert: Director James Hawkins Sells Shares of iRadimed Corp (IRMD)

GuruFocus.com

7 months ago

Insider Sell Alert: Director James Hawkins Sells Shares of iRadimed Corp (IRMD)

Lufax Announces Receipt of Notice Regarding NYSE Continued Listing Standards and Effectiveness of its ADS Ratio Change

PR Newswire

7 months ago

Lufax Announces Receipt of Notice Regarding NYSE Continued Listing Standards and Effectiveness of its ADS Ratio Change

CSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates at Three Years Post-Treatment Long-Term Durability, Safety and Greater Bleed Protection Versus Prophylactic Treatment in People Living with Hemophilia B

PR Newswire

8 months ago

CSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates at Three Years Post-Treatment Long-Term Durability, Safety and Greater Bleed Protection Versus Prophylactic Treatment in People Living with Hemophilia B

12 Best Genomics Stocks To Buy Now

Insider Monkey

8 months ago

12 Best Genomics Stocks To Buy Now

uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

15 Best Falling Stocks To Buy Now

Insider Monkey

8 months ago

15 Best Falling Stocks To Buy Now

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Insider Sell: EVP, General Counsel & Sec Vaishali Bhatia Sells 18,465 Shares of HF Sinclair ...

GuruFocus.com

8 months ago

Insider Sell: EVP, General Counsel & Sec Vaishali Bhatia Sells 18,465 Shares of HF Sinclair ...

Roadzen Joins Hands with IBM, Meta, and Other Industry Leaders as a Founding Member of the AI Alliance to Advance Open, Safe, and Responsible AI

GlobeNewswire

8 months ago

Roadzen Joins Hands with IBM, Meta, and Other Industry Leaders as a Founding Member of the AI Alliance to Advance Open, Safe, and Responsible AI

Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.

GlobeNewswire

8 months ago

Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.

Shareholders in uniQure (NASDAQ:QURE) are in the red if they invested three years ago

Simply Wall St.

8 months ago

Shareholders in uniQure (NASDAQ:QURE) are in the red if they invested three years ago

Portillo's Inc. (NASDAQ:PTLO) is a favorite amongst institutional investors who own 66%

Simply Wall St.

8 months ago

Portillo's Inc. (NASDAQ:PTLO) is a favorite amongst institutional investors who own 66%

Investors in Luther Burbank (NASDAQ:LBC) have unfortunately lost 27% over the last year

Simply Wall St.

8 months ago

Investors in Luther Burbank (NASDAQ:LBC) have unfortunately lost 27% over the last year

uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease

GlobeNewswire

8 months ago

uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease

Does iTeos Therapeutics, Inc. (ITOS) Have the Potential to Rally 283.59% as Wall Street Analysts Expect?

Zacks

8 months ago

Does iTeos Therapeutics, Inc. (ITOS) Have the Potential to Rally 283.59% as Wall Street Analysts Expect?

iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference

GlobeNewswire

8 months ago

iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference

Here's What To Make Of Excelerate Energy's (NYSE:EE) Decelerating Rates Of Return

Simply Wall St.

8 months ago

Here's What To Make Of Excelerate Energy's (NYSE:EE) Decelerating Rates Of Return

Has Benchmark Electronics, Inc.'s (NYSE:BHE) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Simply Wall St.

8 months ago

Has Benchmark Electronics, Inc.'s (NYSE:BHE) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

3 Micro-Cap Stocks That Could Be Moonshots

InvestorPlace

8 months ago

3 Micro-Cap Stocks That Could Be Moonshots

Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences

GlobeNewswire

9 months ago

Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2023 Earnings Call Transcript

Fulcrum Therapeutics Inc (FULC) Reports Q3 2023 Financial Results and Business Highlights

GuruFocus.com

9 months ago

Fulcrum Therapeutics Inc (FULC) Reports Q3 2023 Financial Results and Business Highlights

Share on Social Networks: